Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo di Procolo

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Plos Neglected Tropical Diseases|September 5, 2014
Current pipelines for neglected diseasesPaolo di Procolo, Claudio Jommi
Recenti Progressi in Medicina|September 13, 2024
[Human vs. ChatGPT. Is it possible obtain comparable results in the analysis of a scientific systematic review?]Chiara Esposito, Giulia Dell'Omo, Daniele Di Ianni, et al.
Plos One|August 11, 2012
Arginine-specific mono ADP-ribosylation in vitro of antimicrobial peptides by ADP-ribosylating toxinsMarta Castagnini, Monica Picchianti, Eleonora Talluri, et al.
Pharmacoeconomics - Open|April 7, 2018
The Cost of Patients with Chronic Kidney Failure Before Dialysis: Results from the IRIDE Observational StudyClaudio Jommi, Patrizio Armeni, Margherita Battista, et al.
Neurology International|April 26, 2024
Utilization of Ocrelizumab within Different Treatment Strategies for Multiple Sclerosis: A 5-Year Population-Based StudyMarcello Moccia, Giuseppina Affinito, Giuseppina Marrazzo, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Plos Neglected Tropical Diseases|September 5, 2014
Current pipelines for neglected diseasesPaolo di Procolo, Claudio Jommi
Recenti Progressi in Medicina|September 13, 2024
[Human vs. ChatGPT. Is it possible obtain comparable results in the analysis of a scientific systematic review?]Chiara Esposito, Giulia Dell'Omo, Daniele Di Ianni, et al.
Plos One|August 11, 2012
Arginine-specific mono ADP-ribosylation in vitro of antimicrobial peptides by ADP-ribosylating toxinsMarta Castagnini, Monica Picchianti, Eleonora Talluri, et al.
Pharmacoeconomics - Open|April 7, 2018
The Cost of Patients with Chronic Kidney Failure Before Dialysis: Results from the IRIDE Observational StudyClaudio Jommi, Patrizio Armeni, Margherita Battista, et al.
Neurology International|April 26, 2024
Utilization of Ocrelizumab within Different Treatment Strategies for Multiple Sclerosis: A 5-Year Population-Based StudyMarcello Moccia, Giuseppina Affinito, Giuseppina Marrazzo, et al.
Pageof 1